Status:
UNKNOWN
Trial of pRehospital Intervention With trAditional Chinese Medicine for Acute strokE
Lead Sponsor:
Dongzhimen Hospital, Beijing
Collaborating Sponsors:
Beijing Emergency Medical Center
Beijing Tiantan Hospital
Conditions:
Stroke
Acute Ischemic Stroke
Eligibility:
All Genders
18+ years
Brief Summary
The main purpose of this trial is to observe whether Xingnaojing, intravenously administered within 24 hours of symptom onset on pre-hospital emergency ambulance, improves the Early neurological deter...
Detailed Description
The TRACE is a multicenter, registry observational study. Xingnaojing injection is the only essential traditional chinese medicine on emergency ambulance used for acute stroke.The primary hypothesis o...
Eligibility Criteria
Inclusion
- Diagnosis of suspected acute stroke；
- Symptom onset within 24 hours；
- Age ≥ 18 .
Exclusion
- Other conditions that lead to motor dysfunction (e.g., severe osteoarthrosis, rheumatoid arthritis);
- Other conditions that render outcomes or follow-up unlikely to be assessed; Known to be pregnant or breastfeeding;
- Non-acute stroke (result from Computed Tomography(CT) or Magnetic Resonance Imaging(MRI)).
Key Trial Info
Start Date :
March 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04275349
Start Date
March 20 2020
End Date
December 1 2020
Last Update
June 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dongzhimen Hospital
Beijing, Beijing Municipality, China, 100700